In vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts
Article in Frontiers in Oncology (November 2022)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Advances in the development of chordoma models for drug discovery and precision medicine
Article in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (October 2022)
Molecular Morphogenesis and Genetic Mechanisms of Spinal Chordoma
Book chapter (July 2021)